Business Update

Misonix is first ever to participate in HIFU for treating prostate cancer in Hungary

Published in Cancer Weekly, December 12th, 2006

Misonix, Inc. (MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, announced it will participate in a high intensity focused ultrasound (HIFU) procedure in Hungary using the Sonablate 500 for the treatment of prostate cancer.

The SOTE Urological Clinic at the University Hospital of Budapest, with Imre Romics, has been the first to perform HIFU. Commenting on being the first in Hungary, Romics stated, "We are excited to be the first to introduce minimally invasive, visually directed HIFU to the prostate cancer patients of Hungary. We are encouraged with the reported low morbidity and high curative...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2006-12-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry